相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes
Anne Daly et al.
NUTRIENTS (2021)
Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1
Ozlem Yilmaz et al.
NUTRIENTS (2020)
Type 1 tyrosinemia in Finland: a nationwide study
Linnea Aarela et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Nutritional and Metabolic Characteristics of UK Adult Phenylketonuria Patients with Varying Dietary Adherence
Benjamin Green et al.
NUTRIENTS (2019)
The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients
Willem G. van Ginkel et al.
NUTRIENTS (2019)
Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice
Willem G. van Ginkel et al.
NUTRIENTS (2019)
Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1
Willem G. van Ginkel et al.
PEDIATRIC DRUGS (2019)
The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis
Maria Joao Pena et al.
NUTRIENTS (2018)
Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations
Jeffrey M. Chinsky et al.
GENETICS IN MEDICINE (2017)
Glycomacropeptide Sustains Microbiota Diversity and Promotes Specific Taxa in an Artificial Colon Model of Elderly Gut Microbiota
Alexandra Ntemiri et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
A. Daly et al.
JOURNAL OF HUMAN NUTRITION AND DIETETICS (2017)
Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls
Willem G. van Ginkel et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice
Emily A. Sawin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Validation of bovine glycomacropeptide as an intestinal anti-inflammatory nutraceutical in the lymphocyte-transfer model of colitis
Mercedes Ortega-Gonzalez et al.
BRITISH JOURNAL OF NUTRITION (2014)
Nutritional and medicinal aspects of D-amino acids
Mendel Friedman et al.
AMINO ACIDS (2012)
Adherence Issues in Inherited Metabolic Disorders Treated by Low Natural Protein Diets
A. MacDonald et al.
ANNALS OF NUTRITION AND METABOLISM (2012)
Increase of CSF tyrosine and impaired serotonin turnover in tyrosinemia type I
Eva Thimm et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Nutritional management of PKU with glycomacropeptide from cheese whey
D. M. Ney et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients
A. Masurel-Paulet et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKU
Kyungwha Lim et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Bioactive properties of milk proteins with particular focus on anticariogenesis
WR Aimutis
JOURNAL OF NUTRITION (2004)
Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy
PB Acosta et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2003)
The role and potential of sialic acid in human nutrition
B Wang et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2003)
Phenylalanine supplementation improves the phenylalanine profile in tyrosinaemia
CJ Wilson et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2000)